<DOC>
	<DOCNO>NCT01218347</DOCNO>
	<brief_summary>This study aim explore influence organic anion transport polypeptide1B1 ( OATP1B1 ) genotype pharmacokinetics , lipid lower effect lipid profile rosuvastatin administration .</brief_summary>
	<brief_title>Influence Organic Anion Transporting Polypeptide1B1 ( OATP1B1 ) Genotype Rosuvastatin PK , PD Lipid Profiles</brief_title>
	<detailed_description>Open , one arm , single sequence study healthy volunteer investigate . Thirty four subject may enrol . Rosuvastatin administer day 21 day . Before rosuvastatin administration , PK , PD lipid profile investigate .</detailed_description>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Age : Between 20 50 year age , inclusive ( age base date give inform consent ) Weight : Over 55 kg , within Â±20 % ideal body weight Must reliable willing make available study period Must willing give blood sample genotyping History significant clinical illness need medical caution , include cardiovascular , immunologic , hematologic , neuropsychiatric , respiratory , gastrointestinal , hepatic , renal disease chronic disease History significant surgical resection gastrointestinal tract except appendectomy History evidence drug abuse Use medication last 14 day period first dose Hypersensitivity HMGCoA reductase inhibitor Judged inappropriate study investigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>OATP1B1</keyword>
	<keyword>rosuvastatin</keyword>
</DOC>